Globus Medical Inc news

   Watch this stock
Showing stories 1 - 10 of about 75   

Articles published

GMED 23.58 -1.39 (-5.57%)
price chart
Why Globus Medical Inc. Shares Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
Globus Medical Announces Acquisition of Transplant Technologies of Texas
AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal implant manufacturer, today announced that it has acquired allograft tissue processor Transplant Technologies of Texas, Ltd.
Related articles »  
Brokerage Firm Price Target on Globus Medical Inc
Equity analysts at the Brokerage firm JMP Securities maintains its rating on Globus Medical Inc (NYSE:GMED). The rating major has initiated the coverage with an market outperform rating on the shares.
Globus Medical Announces Preliminary Q4 amp; 2014 Sales Results
Musculoskeletal implant manufacturer, Globus Medical Inc. (GMED - Snapshot Report) recently announced preliminary sales result for the fourth quarter and full-year 2014.
Globus Medical Reports Preliminary Fourth Quarter and Full Year Sales Results  MarketWatch
Related articles »  
Globus Medical Tanks On Lowered Guidance
Globus Medical Inc (GMED) announced its second-quarter financial results for fiscal'14 (2QFY14; ended June 30) yesterday.
Globus Medical, Inc. (GMED) Reports In-Line Q2 EPS; Cuts FY14 Revenue ... (subscription)
Related articles »  
Globus Medical Announces Acquisition of Robotics Developer Excelsius Surgical
AUDUBON, Pa., Jan 08, 2014 (BUSINESS WIRE) -- Globus Medical, Inc. GMED, -0.53% a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical.
Globus Medical acquires Excelsius Surgical
Related articles »  
Sector Volume Movers: Globus Medical Inc , Oncothyreon Inc , Ryder System Inc
Investors in Globus Medical Inc (GMED) found the counter bleeding as the shares closed down 0.5267% or 0.13 points. The trading commenced at 24.83 and the shares soon toppled to hit a low of 24.47.
Canaccord Genuity Reiterates $28.00 Price Target for Globus Medical (GMED)  Dakota Financial News
Thursday Investors Are Watching: Globus Medical, Inc. (GMED), Seneca Foods ...  WallStreet Scope
Commit To Buy Globus Medical At $20, Earn 7.7% Annualized Using Options
Investors considering a purchase of Globus Medical Inc (Symbol: GMED) shares, but tentative about paying the going market price of $24.50/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Globus Medical Reports 2014 Third Quarter Results
Mr. Baron, who is resigning to pursue other interests, will remain with the Company to assist with the transition during the search for his replacement.
Globus Medical Results Top Estimate, CFO Rick Baron Resigns; Stock Down 4%  Nasdaq
Globus Medical (GMED) Tops Q3 EPS by 3c; Announces CFO Resignation (subscription)
Related articles »  
Globus Medical (GMED) Upgraded From Hold to Buy
The gross profit margin for GLOBUS MEDICAL INC is currently very high, coming in at 81.06%. It has increased from the same quarter the previous year.
Related articles »